MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.

@article{Sanctis2008MACOPBAI,
  title={MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.},
  author={Vitaliana de Sanctis and Erica Finolezzi and Mattia Falchetto Osti and Lavinia Grapulin and Marco Alf{\`o} and Edoardo Pescarmona and Francesca Berardi and Fiammetta Natalino and Maria Luisa Moleti and Alice di Rocco and Riccardo Maurizi Enrici and Robin Fo{\'a} and Maurizio Martelli},
  journal={International journal of radiation oncology, biology, physics},
  year={2008},
  volume={72 4},
  pages={1154-60}
}
PURPOSE To report the clinical findings and long-term results of front-line, third-generation MACOP-B (methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin) chemotherapy and mediastinal involved-field radiotherapy (IFRT) in 85 consecutive, previously untreated patients with primary mediastinal large B cell lymphoma (PMLBCL) diagnosed and managed at a single institution. METHODS AND MATERIALS Between 1991 and April 2004, 92 consecutive, untreated patients with… CONTINUE READING
13 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Similar Papers

Loading similar papers…